A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis

Inclusion Criteria

• •Male or female between the ages of 18 and 75 years.
• •Participants with a diagnosis of plaque psoriasis (psoriasis vulgaris) for at least 6 months.
• •Have a PASI score of 12 or greater AND a Physician Global Assessment score of 3 (moderate) or 4 (severe).
• •Have plaque-type psoriasis covering at least 10 % of total body surface area (BSA).